Cord stem cell treatment for people with multiple sclerosis
Treatments studied
Part of Brain & nervous system, Immune system & allergy clinical trials.
This Phase 1/2 trial studies whether donated umbilical cord stem cells are safe and can improve multiple sclerosis. It aims to see if the treatment is workable for people who still have active MS despite standard therapies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are willing to sign informed consent.
- You’re age 20 to 65.
- You have multiple sclerosis that is relapsing-remitting or secondary progressive, and it’s been active recently (relapses and/or MRI changes).
- Your MS has been diagnosed within the last 2 to 15 years, and your disability score is between 2.0 and 6.5.
- Your blood clotting tests are near normal (PT and APTT no more than 1.5 times the lab’s upper limit).
- You’ve tried at least one MS disease medicine for more than 6 months and still had ongoing disease activity.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early study tests whether an IV infusion of donor-derived stem cells is safe for people with multiple sclerosis. It mainly focuses on side effects and safety, not whether it improves MS symptoms yet.
This trial uses your own blood stem cells to reboot your immune system, which may help stop multiple sclerosis attacks and slow disability. It is for people with active MS that has not responded well to other treatments.
This trial tests a new way to treat primary progressive multiple sclerosis (PPMS) using a stem cell transplant from a healthy donor. The goal is to see if this approach can stop or slow the disease and improve quality of life.
This early-phase study tests a stem cell transplant procedure for people with multiple sclerosis whose usual MS medicines have not worked or can’t be tolerated. The goal is to see if this approach can help control MS activity and progression, while checking for safety.
This study tests whether stem cells from donated fat tissue can slow down primary progressive multiple sclerosis. You would receive a single injection of the cells into your spinal fluid and be followed for up to 2 years.
This study tests a new treatment that combines a type of immune cell therapy with a targeted antibody to see if it can help people with multiple sclerosis. It aims to reduce the immune system's attack on the nervous system and potentially slow disease progression.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.